Detoxification mechanisms and tumor cell resistance to anticancer drugs. 1991

S Kuzmich, and K D Tew
Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

S Kuzmich, and K D Tew
May 2006, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
S Kuzmich, and K D Tew
May 1991, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement,
S Kuzmich, and K D Tew
April 1998, International journal of oncology,
S Kuzmich, and K D Tew
November 1996, Presse medicale (Paris, France : 1983),
S Kuzmich, and K D Tew
November 2021, Biochemical pharmacology,
S Kuzmich, and K D Tew
January 2022, Therapeutic advances in medical oncology,
S Kuzmich, and K D Tew
August 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Kuzmich, and K D Tew
January 2007, Advances in experimental medicine and biology,
S Kuzmich, and K D Tew
November 2013, The New England journal of medicine,
S Kuzmich, and K D Tew
January 1963, Advances in cancer research,
Copied contents to your clipboard!